Filing excerpt
Our results for the second quarter of 2026 and 2025 included business optimization charges of $7 million and $17 million, respectively. Our results for the first six months of 2026 and 2025 included business optimization charges of $75 million and $62 million, respectively. These restructuring and business optimization costs primarily related to initiatives to reduce our cost structure following the sale of our former Kidney Care business.